10.1 Chronic Insomnia: ICSD-3 Classification & Assessment

10.1 Chronic Insomnia: ICSD-3 Classification & Assessment

Quick Answer: Under the International Classification of Sleep Disorders, Third Edition (ICSD-3), Chronic Insomnia Disorder is defined as a persistent difficulty with sleep initiation, sleep maintenance or early morning awakening (commonly quantified as more than 30 minutes of sleep latency or wake after sleep onset), occurring despite adequate opportunity and circumstances for sleep, associated with daytime functional impairment, occurring at least 3 nights per week for at least 3 months. Short-Term Insomnia Disorder shares these symptomatic criteria but lasts less than 3 months, typically precipitated by an identifiable acute stressor. Insomnia is maintained according to Spielman's 3P Model: predisposing traits lower the insomnia threshold, precipitating events trigger acute sleep disturbance, and perpetuating behavioral adaptations (such as excessive time in bed, daytime napping, and clock-watching) chronically entrench the disorder. Polysomnography (PSG) is not routinely indicated for chronic insomnia unless comorbid sleep apnea, periodic limb movements, or paradoxical insomnia are suspected.

Insomnia is the most common sleep disorder encountered in clinical sleep health practice. Rather than representing a uniform single symptom, insomnia encompasses a heterogeneous constellation of nocturnal disturbances and daytime neurobehavioral impairments. For the Clinical Sleep Health Specialist (CCSH), mastering standard diagnostic classification, behavioral modeling, neuroendocrine hyperarousal, and comprehensive assessment protocols is essential for establishing targeted interventions.

Diagnostic Criteria Under ICSD-3

The American Academy of Sleep Medicine (AASM) consolidated previous categorical subtypes (such as psychophysiological, idiopathic, and paradoxical insomnia) into unified diagnostic categories within the International Classification of Sleep Disorders, Third Edition (ICSD-3) and its text revision (ICSD-3-TR):

Core Diagnostic Requirements

To meet the diagnostic criteria for an insomnia disorder, an adult patient must report:

1. Sleep Complaint (at least one):
   • Difficulty initiating sleep (sleep-onset insomnia): Prolonged sleep onset latency (SOL), commonly quantified as more than 30 minutes in adults (more than 20 minutes in children and young adults); ICSD-3 itself sets no minute threshold.
   • Difficulty maintaining sleep (sleep-maintenance insomnia): Frequent or prolonged nocturnal awakenings, commonly quantified as wake after sleep onset (WASO) of more than 30 minutes.
   • Early morning awakening (terminal insomnia): Waking well before the desired time (often quantified as at least 30 minutes early) and being unable to get back to sleep.
   • In children or adults who depend on caregivers: resistance to going to bed on an appropriate schedule, or difficulty sleeping without a parent or caregiver.
2. Adequate Opportunity and Circumstances: The nocturnal sleep disturbance occurs despite adequate time allotted for sleep and an environment conducive to rest. This criterion distinguishes clinical insomnia from voluntary sleep restriction, societal work-hour deprivation, or inadequate environmental sleeping conditions.
3. Daytime Functional Impairment or Distress (at least one):
   • Cognitive fatigue, low energy, or general malaise.
   • Attention, concentration, or memory impairment.
   • Impaired occupational, academic, social, or interpersonal performance.
   • Mood disturbance, irritability, or affective dysregulation.
   • Excessive daytime sleepiness (though rarely actual sleep attacks).
   • Reduced motivation, initiative, or drive.
   • Increased proneness to accidents or operational errors at work or while driving.
   • Musculoskeletal tension, tension-type headaches, or gastrointestinal distress.
   • Preoccupying concerns, anticipatory anxiety, or catastrophic worrying regarding sleep quality.

Temporal Categorization: Chronic vs. Short-Term Insomnia

ICSD-3 delineates insomnia according to frequency and chronological duration:

• Chronic Insomnia Disorder: The sleep disturbance and accompanied daytime symptoms occur at a frequency of at least 3 nights per week and persist for an uninterrupted duration of at least 3 months.
• Short-Term Insomnia Disorder (Acute / Adjustment Insomnia): Symptoms satisfy the nocturnal and daytime criteria and occur at least 3 nights per week, but have been present for less than 3 months. It is usually temporally linked to an acute identifiable medical, psychological, psychosocial, or environmental stressor (e.g., divorce, bereavement, acute pain, job transition).
• Other Insomnia Disorder: Reserved for sleep disturbances where the patient reports symptoms of insomnia that cause clinical distress but fail to satisfy the full frequency or symptom thresholds of chronic or short-term insomnia.

---

Neurobiological Hyperarousal Theory of Insomnia

Historically viewed merely as an inability to sleep or a failure of the brain's sleep-inducing neural networks, modern neurobiology conceptualizes chronic insomnia as a disorder of continuous, 24-hour physiological, neuroendocrine, and cortical hyperarousal:

Neuroendocrine & Autonomic Hyperarousal

• Hypothalamic-Pituitary-Adrenal (HPA) Axis Dysregulation: Patients with chronic insomnia exhibit increased 24-hour secretion of adrenocorticotropic hormone (ACTH) and nocturnal cortisol. The normal circadian nadir of cortisol that occurs during the early night is blunted, producing systemic hypercortisolemia.
• Sympathetic Autonomic Tone: Heart rate variability (HRV) spectral analysis reveals heightened low-frequency sympathetic activity and decreased high-frequency parasympathetic vagal tone across both wakefulness and NREM sleep. Patients display elevated 24-hour systemic metabolic rates (increased whole-body oxygen consumption, $VO_2$) and elevated nocturnal core body temperatures.

Cortical Hyperarousal & Quantitative EEG

• High-Frequency Spectral Power: Quantitative electroencephalography (qEEG) demonstrates elevated power in high-frequency bands—specifically beta (15–30 Hz) and gamma (>30 Hz) oscillations—during non-rapid eye movement (NREM) sleep.
• Micro-Arousal & Sleep State Misperception: While conventional polysomnographic scoring categorizes epochs as N2 or N3 slow-wave sleep based on dominant delta or spindle activity, co-existing beta/gamma intrusion reflects ongoing cortical sensory processing and memory encoding. This persistent neurophysiologic activation explains why patients often perceive that they were awake and thinking when objective recording confirms physiological sleep.

---

Spielman's 3P Behavioral Model of Insomnia

Formulated by Arthur Spielman, the 3P Model serves as the primary clinical framework for conceptualizing the development, evolution, and chronification of insomnia across three dynamic factors:

[ Predisposing Factors ] (Baseline trait vulnerability)
          +
[ Precipitating Factors ] (Acute life trigger / stressor)
          ↓
   [ Acute Insomnia ]
          +
[ Perpetuating Factors ] (Compensatory maladaptive habits)
          ↓
  [ Chronic Insomnia ]

1. Predisposing Factors (Vulnerability)

Predisposing factors represent internal, enduring traits that lower an individual's physiological threshold for sleep disruption:

• Biological / Genetic: Elevated baseline autonomic tone, heightened trait arousal, family history of insomnia, female biological sex, and advanced age.
• Psychological Traits: Tendency toward rumination, neuroticism, perfectionistic standards, chronic anxiety diathesis, internalizing coping styles, and hyper-reactivity to stress.
• Clinical Pearl: Predisposing factors make an individual vulnerable, but alone they rarely trigger full insomnia without an acute precipitant.

2. Precipitating Factors (Triggers)

Precipitating factors are acute, time-limited events that trigger the initial onset of acute sleep disturbance:

• Medical / Physical: Acute illness, traumatic physical injury, surgical procedures, acute somatic pain, or hormonal shifts (e.g., postpartum, menopause).
• Psychosocial Stressors: Bereavement, marital divorce, interpersonal conflict, sudden job loss, academic examinations, or acute financial distress.
• Environmental: Extreme noise disruption, acute shift work schedule changes, or hospitalization.
• In individuals with low predisposing vulnerability, sleep naturally normalizes once the acute crisis resolves. In vulnerable individuals, however, acute sleep disturbance activates maladaptive coping behaviors.

3. Perpetuating Factors (Maintaining Mechanisms)

Perpetuating factors are maladaptive behavioral, cognitive, and environmental adaptations adopted by the patient to cope with sleep loss. While intended to alleviate fatigue, these mechanisms paradoxically sustain and chronify insomnia long after the original precipitating trigger has completely resolved:

• Extending Time in Bed (TIB): Going to bed excessively early or remaining in bed late into the morning to "catch up" on lost sleep. This expands time in bed relative to total sleep time, diluting homeostatic sleep pressure and fragmenting sleep architecture.
• Daytime Napping: Taking prolonged daytime naps, which discharges homeostatic adenosine (Process S) and diminishes nocturnal sleep drive.
• Clock-Watching (Temporal Monitoring): Checking the bedroom clock during awakenings, triggering immediate cognitive appraisal, mathematical calculations of remaining sleep time, and autonomic arousal.
• Conditioned Bedroom Arousal: Spending hours lying awake in bed tossing, turning, reading, working, or watching television. Over time, the bed and bedroom become conditioned stimuli paired with frustration, vigilance, and wakefulness rather than sleep.
• Catastrophic Worrying: Hyper-focusing on sleep quality and entertaining catastrophic beliefs regarding the devastating daytime consequences of sleep loss.
• Target of Therapy: Perpetuating factors represent the primary target of Cognitive Behavioral Therapy for Insomnia (CBT-I).

---

Comprehensive Assessment & Clinical Evaluation

The clinical evaluation of chronic insomnia is primarily conducted through a structured subjective clinical interview and objective sleep-tracking tools:

Two-Week Sleep Diary / Sleep Log

The consensus sleep diary represents the gold-standard assessment instrument in clinical sleep health. Completed immediately upon waking each morning for at least 14 consecutive days, it allows calculation of core clinical metrics:

• Sleep Onset Latency (SOL): Average minutes from lights-out to sleep onset (pathological if $>30$ min).
• Wake After Sleep Onset (WASO): Total minutes of wakefulness occurring between initial sleep onset and final morning awakening (pathological if $>30$ min).
• Total Sleep Time (TST): Total minutes or hours of actual sleep obtained ($\text{TST} = \text{TIB} - [\text{SOL} + \text{WASO} + \text{terminal wake}]$).
• Time in Bed (TIB): Total duration from going to bed with intention to sleep until rising out of bed for the day.
• Sleep Efficiency (SE%): The fundamental mathematical indicator of sleep consolidation: $\text{SE}\% = \left( \frac{\text{TST}}{\text{TIB}} \right) \times 100$
  • Normal / Consolidated Sleep: $\text{SE} \ge 85\%$ (or $\ge 90\%$ in healthy young adults).
  • Insomnia / Fragmented Sleep: $\text{SE} < 80\%$ (frequently $60\%\text{--}75\%$).

Validated Questionnaires & Clinical Stratification

• Insomnia Severity Index (ISI): A 7-item validated questionnaire evaluating symptom severity, distress, and daily impairment over the past 2 weeks (scored 0–28):
  • 0–7: No clinically significant insomnia.
  • 8–14: Subthreshold (mild) insomnia.
  • 15–21: Clinical insomnia of moderate severity.
  • 22–28: Severe clinical insomnia.
  • A reduction of $\ge 6$ points indicates a clinically meaningful response to therapy.
• Dysfunctional Beliefs and Attitudes About Sleep (DBAS-16): Evaluates cognitive distortions, unrealistic sleep expectations, and catastrophic attributions regarding sleep deprivation.
• Epworth Sleepiness Scale (ESS): Assesses propensity for daytime dozing.
  • The CCSH Diagnostic Pearl: Patients with primary chronic insomnia typically report profound fatigue, lethargy, and physical exhaustion, but maintain normal or low daytime sleepiness scores ($\text{ESS} < 10$) due to persistent 24-hour physiological hyperarousal. An elevated ESS score ($\ge 10$) in a patient presenting with insomnia strongly points toward an occult comorbid sleep disorder, such as obstructive sleep apnea (OSA) or narcolepsy.

Polysomnography (PSG) Indications in Insomnia

American Academy of Sleep Medicine clinical practice guidelines explicitly state that in-laboratory polysomnography (PSG) is NOT routinely indicated for the standard evaluation or diagnosis of chronic insomnia disorder. Chronic insomnia is diagnosed clinically via history and diaries.

Strict Clinical Indications for PSG in Insomnia:

1. Clinical suspicion of comorbid sleep-related breathing disorders (e.g., habitual snoring, witnessed apneas, nocturnal choking, elevated BMI).
2. Clinical suspicion of periodic limb movement disorder (PLMD) contributing to sleep fragmentation.
3. Suspected parasomnias or atypical, violent sleep-related behaviors.
4. Severe, unexplained treatment failure refractory to comprehensive evidence-based CBT-I.
5. Evaluation of suspected Paradoxical Insomnia (Sleep State Misperception): PSG is required to demonstrate preserved objective sleep architecture, normal total sleep time, and normal sleep efficiency despite the patient's subjective perception of total sleeplessness.

---

Comparison: Insomnia Subtypes & Related Disorders